Answers are grounded in this paper and cite their sources.
Background/Objectives: Total serum bile acid (TSBA) testing supports evaluation and monitoring of cholestatic disorders. However, its real-world utilization and result distributions remain poorly characterized in Korea. We therefore assessed nationwide patterns using retrospective referral laboratory data. Methods: We retrospectively analyzed serum TSBA test results from specimens referred nationwide to a large referral clinical laboratory in Korea between 16 June 2025, and 30 May 2026. Initial TSBA concentrations were categorized as <10, 10–<40, 40–<100, and ≥100 μmol/L. Test utilization, follow-up patterns, pediatric and obstetric subgroups, and factors associated with elevated initial TSBA concentrations were evaluated. National utilization trends were assessed using Health Insurance Review and Assessment Service (HIRA) claims data. Results: During the approximately 1-year study period, 13,072 TSBA records from 11,543 subjects were included. Initial TSBA concentrations were <10 μmol/L in 81.0%, 10–<40 μmol/L in 14.3%, 40–<100 μmol/L in 2.7%, and ≥100 μmol/L in 2.1%. Follow-up testing was performed in 9.8%. Among children aged < 10 years, 22.4% had initial TSBA concentrations ≥ 100 μmol/L. In the obstetric hospital female subgroup, 94.7% had initial TSBA concentrations < 10 μmol/L. Test orders from infants and those originating from university hospitals were associated with higher odds of elevated initial TSBA concentrations across all predefined cutoffs. HIRA claims data showed increasing national utilization, including among pediatric populations and women aged 20–49 years. Conclusions: This study describes TSBA testing utilization patterns and result distributions across different referral settings using data from a large nationwide referral laboratory in Korea.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: